SwissDTX FOR

Scientific Research

Remote participation for modern research.
Challenge
Traditional clinical trials face high dropout rates and logistical barriers. Decentralized Clinical Trials (DCTs) can reduce costs by 30 % but require reliable digital infrastructure (McKinsey 2024).
Solution
SwissDTx offers a secure, intervention-agnostic platform for running decentralized or hybrid trials. Researchers distribute screeners, collect longitudinal data, and maintain participant engagement through digital interventions.
The Potential we See
↓ 40 %
dropout reduction in app-supported trials (Nature Digital Medicine, 2023).

Bringing research closer to real life — and real people.

‍

Introduction

Clinical research is evolving. Traditional, site-based studies often struggle to reflect the complexity of real-world settings — where participants live, work, and recover. SwissDTx enables a new way of conducting studies: decentralized clinical trials (DCTs) that seamlessly combine digital and in-person participation. Researchers can deploy validated interventions, collect data remotely, and monitor outcomes continuously — all within a secure, compliant, and user-friendly platform.

By bridging the gap between science and daily life, SwissDTx helps transform how evidence is generated, analyzed, and translated into better care.

‍

Common Challenges for Researchers

Running clinical research is demanding — and decentralized studies add new layers of complexity.
Researchers often face challenges such as:

  • Recruitment and retention: Engaging and motivating participants across locations and time zones can be difficult.
  • Data quality and adherence: Ensuring standardized data collection outside controlled environments is often a major barrier.
  • Regulatory and privacy requirements: Managing consent, secure data transfer, and compliance with GDPR and Swiss data protection laws is time-consuming.
  • Fragmented tools and workflows: Many research teams rely on separate systems for e-consent, data collection, and follow-up, increasing workload and error potential.

These hurdles slow down innovation and limit the potential of evidence-based healthcare.

‍

How SwissDTx Helps

SwissDTx provides an end-to-end digital companion for decentralized and hybrid trials — designed to make participation effortless and data collection seamless.

With SwissDTx, researchers can:

  • Deploy digital interventions and study materials directly to participants’ apps, ensuring consistent and engaging study experiences.
  • Collect real-world data securely through validated screeners, questionnaires, and behavioral metrics — in real time.
  • Monitor adherence and progress through intuitive dashboards that provide visibility into engagement, symptom trends, and outcomes.
  • Ensure regulatory compliance with integrated consent management, secure hosting in Switzerland, and full GDPR alignment.
  • Enhance participant engagement via reminders, educational content, and interactive exercises that keep users motivated and connected.

SwissDTx turns complex study logistics into a connected, scalable, and human-centred research experience — helping researchers focus on what matters most: generating knowledge that improves lives.

‍

Want to see how SwissDTx can support your next study?

CONTACT US

We’d love to hear from you

We’re happy to answer your questions if you schedule a meeting.
Schedule a Call